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418Objective: Our objective was to evaluate long-term stability of mitral repair and reverse remodeling in patients
with severe ischemic left ventricular dysfunction and functional mitral regurgitation.
Methods: Since June 2000, a total of 37 patients with ischemic functional mitral regurgitation have benefited
from a double-level mitral repair that comprises an intraventricular peripapillary muscle sling completed by a clas-
sic intra-atrial mitral annuloplasty ring (mean age, 56 years; left ventricular end-diastolic diameter, 70  0 mm;
left ventricular end-systolic diameter, 55  5.6 mm; ejection fraction, 15% to 45%; pulmonary hypertension>
60 in all patients; all were in New York Heart Association class III-IV). All patients had both papillary muscles
encircled with a 4-mm polytetrafluoroethylene tube, correcting their lateral and downward displacement.
Annuloplasty rings were moderately undersized or normal. Efficiency was evaluated on mitral stability, ventric-
ular parameters, and functional status. According to the Leyden algorithm based on preoperative end-diastolic and
end-systolic left ventricular diameters, only a minority of our patients were expected to experience reverse
remodeling.
Results:Regurgitation is none to trivial in 31 and mild to moderate in 4. Follow-up (3–84 months; mean, 55 22
months) shows stability of all initially successful double-level mitral repairs. Follow-up beyond 1 year shows
improvements in ventricular diameters (56  5 mm), ejection fraction (49  6), volume (130  10 mL), and
sphericity index (0.55). Two patients died during follow-up and 1 underwent transplantation.
Conclusion: Reapproximating the papillary muscles has an immediate effect on mitral leaflet mobility by sup-
pressing the tethering resulting from displacement of the papillary muscles. It has an effect in preventing recurrent
mitral regurgitation by avoiding further papillary muscle displacement. In this cohort of severely disabled patients,
reverse remodeling can be expected with the double-level repair. (J Thorac Cardiovasc Surg 2010;139:418-23)Abnormal displacement of the papillary muscles (PMs)
leading to excessive tension on chordae1,2 has been demon-
strated in patients with left ventricular (LV) dysfunction and
functional mitral regurgitation (FMR). The tethering, re-
stricting mitral leaflet mobility, is instrumental in producing
mitral regurgitation (MR) with an otherwise normal mitral
valve. Mitral repair should consider all the intervening
components, suggesting that correction of FMR should
also focus on some form of intraventricular intervention di-
rected to rectify the PM displacement, relieving tension on
chordae.
On the basis of these considerations, we tested a new ap-
proach that consists in correcting, via the left atrium and
through the mitral orifice, the abnormal displacement of
the PMs using an intraventricular sling (Gore-Tex [polyte-
trafluoroethylene] 4-mm tube; W. L. Gore & Associates,
Inc, Flagstaff, Ariz) encircling the trabecular base of both
PMs. Tightening and securing this sling reapproximatese Department of Cardiovascular Surgery, Bichat Hospital, Paris, France.
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The Journal of Thoracic and Cardiovascular Surgthe two PMs and sets a more normal alignment with the
overhead mitral structures.
Re-establishing the annulus–PM relationship was
expected to relieve the excess tethering on the mitral leaflets
and significantly restore leaflet mobility. A moderately
undersized mitral annuloplasty ring would then complete
the repair. The last 10 patients received a normally sized
prosthetic mitral ring.
The intended procedure would thus comprise a double
mitral ring: one inside the ventricle at the base of the PMs
and the other on the mitral annulus.
Although mitral annuloplasty alone3,4 already offers
symptomatic improvement in patients with FMR, occa-
sionally even seriously undersizing a mitral ring does
not give the anticipated result in terms of correction of
MR. Reported recurrence rates of MR after ring annulo-
plasty alone are far from negligible.5,6 The initial intention
and the expected advantages of this new technique were to
make mitral repair more logical by addressing both com-
ponents of the FMR (the displaced PMs and the annular
deformities). We also expected the procedure to lower
the incidence of recurrent MR resulting from continuing
LV dilation and further displacement of the PMs liable
to increase tension on the mitral chordae. An effect on re-
gional wall motion was also theorized, related to the pos-
terior folding of the left ventricle between the two PMs,7,8
affecting the ratio between volume and mass. After having
initially reported results in 2003,9 we can now give the
medium-term results of this technique, results that loseery c February 2010
TABLE 1. Echocardiographic results after repair for ischemic mitral
regurgitation
Preoperative Six months One year Five years
Age (y) 56 (29–78)
LVEDD (mm) 70  0 62  3.5 56  5.5 55  3.5
LVESD (mm) 55  5.6 51.5  4.9 50  5.5 51  5.5
EF (%) 29.5  5.5 44  13 49  6 45  5
LVV (mL) 250  25 160  18 130  10 122  15
MR 1-2/3-4 7/30 32/3 32/3 31/0
TM gradients 4.8  2.6 3.2  1.6 3.5  1.2 4.4  1
Tenting (mm) 14  2.1 4  1.1 NA NA
IPMD (mm) 3.6  1.2 0,8  0,3 NA NA
Abbreviations and Acronyms
FMR ¼ functional mitral regurgitation
LV ¼ left ventricular
MR ¼ mitral regurgitation
NYHA ¼ New York Heart Association
PMs ¼ papillary muscles
Hvass and Joudinaud Evolving Technology/Basic Sciencesignificance beyond 5 years owing to the small number of
patients.
PAP (mm Hg) >60 35  15 45  11 41  9
Sphericity 0.78 0.68 0.55 NA
S/P wall mm 8/7 10/8 11/8 13/9
NYHAI-II/III-IV 0/37 30/5 31/4 29/2
LVEDD, Left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic
diameter; EF, ejection fraction; LVV, left ventricular volume;MR,mitral regurgitation
grade 1 to 2 over grade 3 to 4; TM gradients, transmitral gradients; IPMD, interpapil-
lary muscle distance; PAP, pulmonary artery pressure; S/P wall, septal/posterior left
ventricular wall thickness; NYHA, New York Heart Association; NA, not available.
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Patients
FMR was diagnosed as ischemic in patients with coronary artery disease
having had inferior and/or lateral myocardial infarctions. The mitral leaflets
were normal, with restricted motion and no other available cause for MR.
Diagnosis was discussed by cardiologists and accepted as such before the
patients were enrolled for the operation. Since June 2000, a total of 37
patients (Table 1) with FMR related to ischemia have benefited from a dou-
ble repair associating an intraventricular peripapillary muscle sling com-
pleted by a classic intra-atrial mitral annuloplasty ring. Ages ranged from
29 to 78 years, mean 56 years. Ejection fraction on angiograms was between
15% and 45%. LV end-diastolic and end-systolic diameters were respec-
tively 70  0 mm and 55  5.6 mm. All patients had a systolic pulmonary
arterial pressure above 60 mm Hg. MR was evaluated as moderate to mod-
erately severe, or 2 to 4 on a scale of 4. Medical therapy was maximal and all
the patients had had several hospital admissions for LV failure. All patients
were in New York Heart Association (NYHA) class III-IV.
Surgical Technique
Once the mitral valve had been exposed and analyzed as anatomically
normal, we placed the stitches on the mitral annulus preparing for the annu-
loplasty. Slight traction on these sutures allows a better exposure of the sub-
valvular apparatus. The position of the anterior PM usually seems normal,
under the anterior mitral commissure. The posterior PM is usually out of
the field and it may be necessary to place a textile under the heart to visualize
it correctly and gain adequate access. We start by working a blunt dissector
through the trabeculations at the base of the posterior PM, ensuring that the
tube will not be able to later migrate toward the head of the PM. The tube is
then drawn around the base of the anterior PM. The loop is progressively
tightened until the two PMs are in close contact. The loop is not squeezed
tight to avoid any ischemia. The 4-mm polytetrafluoroethylene tube forms
an intraventricular ring that is secured with strong sutures. Once tightened,
there is no residual gap between the bases of the two PMs. No sutures are
placed on the PMs themselves. The procedure is completed by mitral annu-
loplasty. Annuloplasty rings are considered of normal size when they cover
the surface of the anterior mitral leaflet. Additional surgery comprised cor-
onary bypass grafts in all patients, tricuspid annuloplasty in 5, and aortic
valve replacement in 1 patient.
Echocardiographic Follow-up
To assess whether this new technique translates into quantifiable criteria,
we evaluated the changes in the tenting effect MR and LV parameters that
comprised LV diameters measured in systole and diastole, volume, spheric-
ity index, and ejection fraction. These changes are compared with the pre-
operative values in Table 1.
Tension on chordae resulting from apical and/or posterior displacement
of the mitral PMs will translate into a tenting effect that can be quantified on
2-dimensional echocardiogram either by the area enclosed between the an-The Journal of Thoracic and Canular plane and mitral leaflets from parasternal long-axis view at early and
late systole or by the vertical distance between leaflet coaptation and the mi-
tral annulus plane. Using the vertical distance criteria, the preoperative tent-
ing measured 14 2.1 mm. The mitral tenting parallels the displacement of
mitral coaptation toward the LV apex. Tenting is not attenuated by annulo-
plasty alone and therefore this feature may serve as an objective criterion to
evaluate the immediate effect of the PM sling on mitral leaflet mobility.
Residual MR was evaluated by transesophageal echocardiography about
3 months postoperatively and usually by transthoracic echocardiography
thereafter.RESULTS (TABLE 1)
Clinical Results
Positioning the intraventricular sling by approaching the
PMs through the mitral orifice was possible in all patients.
Approximating the two PMs immediately unloaded tension
on the mitral chordae, improving leaflet mobility and coap-
tation. Crossclamping time was initially prolonged a mean
28  3.5 minutes. Time devoted to encircling the PMs is
now around 5 minutes.
Mitral annular dilatation was corrected with a moderately
undersized or normally sized ring, sizes 30  2.8 mm. In
preference to the flexible rings we initially used in these pa-
tients, we switched to the Carpentier Physio ring (Baxter
Healthcare Corp, Irvine, Calif) to compensate for the lack
of mitral annular contractility related to ischemic mitral dys-
function.
Coronary bypass grafts comprise 2  1.15 grafts per
patient. The left internal thoracic artery was always used
for the left anterior descending coronary artery. Bilateral
thoracic arteries were not used in any of these patients. Three
patients with coronary stents did not require surgical coro-
nary artery bypass.rdiovascular Surgery c Volume 139, Number 2 419
FIGURE 1. Survival in ‘‘poor responders.’’
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(Figure 1). The 2 patients who died had a preoperative
ejection fraction of 15%, and 1 also had a calcified aortic
valve. Intra-aortic balloon pumping was necessary in 1
patient preoperatively and in 5 other patients after cardiopul-
monary bypass. Two pacemakers were inserted during the
first postoperative month. During the mean follow-up of
55 22 months (range, 3–84 months), the patients were reg-
ularly seen by the referring cardiologist. Two patients were
reoperated on during the third year: 1 had a mitral valve
replacement and the other unsuccessfully underwent trans-
plantation. One patient died of noncardiac disease: a gangre-
nous cholecystitis. At 5 years, 80%were alive. Two of these
patients, although in significantly improved condition and
free from congestive heart failure, continued to receive
higher-dose medications with lower ejection fractions owing
to multiple preoperative infarctions. Beyond 6 years, the
number of patients at risk is too small to be informative.
Two transient ischemic attacks occurred; no endocarditis
or anticoagulant-related bleeding was recorded. Five
patients were on a regimen of long-term anticoagulation.FIGURE 2. Preoperative (A) and postoperative (B) mitral valve, visualiz-
ing the change in mitral tenting (vertical height between the 2 lines) and co-
aptation point.Echocardiographic Results
Echocardiography was performed on a yearly basis in all
patients, either by the referring cardiologist or in the hospital
facilities. Early residual regurgitation was none to trivial in
31 andmild in 2. Results have been stable with no recurrence
or accentuation of MR and no echocardiographic change in
the positioning of the polytetrafluoroethylene sling. In 2
patients residual MR was moderately severe; they under-
went reoperation after 3 years. One patient had had a flexible
mitral ring, and the early unsatisfactory result made us
switch over to rigid rings in these patients to compensate
for the loss of annular contractility. The second patient had
heart transplantation, residual regurgitation having been
explained by our having left out a significant group of pos-
terior PMs that had not been incorporated, unintentionally,
within the sling. The preoperative parameters in these 2
patients did not differentiate them from the entire group.
The tenting effect on the mitral leaflets described by Yiu
and associates1 is considerably attenuated as shown by com-420 The Journal of Thoracic and Cardiovascular Surgparing the preoperative and postoperative 2-dimensional
echocardiograms (Figure 2) even though the PM displace-
ments are probably not fully corrected, in particular the api-
cal displacement. The tenting effect, measured as the
distance between mitral annulus plane and leaflet coaptation,
varies from a preoperative mean value of 14  2.1 mm to
a postoperative mean value of 4  1.1 mm. Patients with
the longer follow-up show no secondary displacement of
the intraventricular sling. The distance between the PMs
changed from a preoperative value of 3.6  1.2 mm to 0.8
 0.3 mm. Postoperative measurements were made at the
level where the sling was detected (Figure 3). Postoperativeery c February 2010
FIGURE 3. Short-axis transgastric echocardiogram showing the position of the papillary muscles (arrows) before (A) and after (B) placement of the intra-
ventricular sling encircling both papillary muscles.
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mean 3.2  1.6 mm Hg.
Preoperative and postoperative LV end-diastolic diame-
ters diminished from 70  0 mm to 62.4  3.5 mm at 6
months and 56  5.5 mm at 1 year. End-systolic LV diam-
eters changed respectively from 55  5.6 mm to 51.5  4.9
mm and 50 5.5 mm. Ejection fractions were, respectively,
29%  5.5%, 44%  13%, and 49%  6% at 1 year (Ta-
ble 1). Pulmonary artery pressure lowered rapidly from
greater than 60 mm Hg to 35  15 mm Hg at 6 months
except in patients with significant residual MR who under-
went reoperation.
At 6 months, functional status improved from NYHA III-
IV to NYHA I-II in all patients except the 2 who needed
reinterventions.
DISCUSSION
In patients with ischemic FMR, local LV alterations
mainly affect the posterior PM and the posterior and lateral
LV wall. Chordal tethering subsequent to local remodeling
intensifies MR that reflects the incomplete leaflet coaptation.
A cascade of dysfunctional remodeling is initiated that com-
prises a mutual intricacy of further ventricular dilatation,
augmented chordal tethering,MR, annular dilatation, and in-
creased heart failure. Mortality in patients with dilated heart
failure is related to the severity of LV systolic dysfunction,
whereas FMR is a marker of poorer prognosis10 with a 1-
year mortality reported between 54% and 70%.
Surgical management classically relies on significantly
undersizing the mitral annuloplasty ring, decreasing valve
area to increase leaflet apposition, and aiming to compensate
for the reduced amplitude of mitral leaflet mobility as well as
the loss of systolic annular contraction.The Journal of Thoracic and CaSuch repairs reported by Bolling and associates,3
although taking into account only one of the components
of FMR, claim 1- and 2-year survivals of 80% and 70%
and demonstrate improvements for ejection fraction and car-
diac output, NYHA class, and peak maximal volume of
oxygen. These results are considered to reflect efficient re-
modeling with a reduction in sphericity index, regurgitant
fraction, and end-diastolic volumes. Significantly undersiz-
ing the mitral annular remodeling ring overcorrects the coap-
tation zone and is thought to contribute to improvement seen
in these myopathic hearts through acute remodeling of the
base of the heart.
After more than a decade of enthusiasm generated by the
pioneering works of Bolling and associates,3 discordant voi-
ces were heard claiming that MR recurs in 20% to 50% of
the cases after only a few years. Recurrent MR after an ini-
tially successful mitral annuloplasty may be related to con-
tinuing PM displacement that augments the tethering on
the leaflets, deranging once more the ratio between mitral or-
ifice and covering surface of the mitral leaflets.
Recurrent MR seemed to be related to continuing or insuf-
ficient reversal of LV adverse remodeling.11,12 Thus two
populations emerged according to the ventricular reaction:
‘‘good responders’’ and ‘‘poor responders,’’ whom the Ley-
den algorithm separated according to the preoperative LV
diameters.13,14 If an undersized mitral ring with a good
coaptation height may be sufficient in good responders,
how should one address the left ventricle in patients who
were poor or boarderline responders?
Several new lines of investigation15-20 have been or are
being evaluated, such as intraventricular patch remodeling
and volume reduction of the left ventricle, plicating the pos-
terior LV wall from the outside and bringing the PMs closerrdiovascular Surgery c Volume 139, Number 2 421
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rior leaflet is also expected to relieve tension on the leaflet
and enhance mobility of the mitral leaflets, but concern
has been expressed regarding the role of these particular
chordae in ventricular remodeling.
The papillary muscle sling has a double effect:
1. The sling addresses the mitral valve by proposing a repair
that takes the mitral apparatus into account as a whole
functioning unit. Furthermore, by suppressing the possi-
bility of continual lateral papillary muscle displacement,
the sling prevents recurrent mitral leaks. None of our pa-
tients with an initially perfect result, although the mean
follow-up is only of 36 months, showed any secondary
change compared with the initial result.
2. The sling also addresses the left ventricle. By this trans-
mitral approach, plicating the posterior wall of the left
ventricle from the inside, the sling acutely changes the
shape and the volume of the left ventricle. Shortening
the posterior LV free wall between the bases of the two
PMs (Figure 3) has an effect on regional wall motion.
Echocardiographic follow-up in our patients, who were
all poor or borderline responders in terms of predictable
remodeling, show that the LV diameters consistently
shorten, ejection fraction increases, volumes melt, sphe-
ricity indexes improve, and the LV walls thicken,
whereas functional status and survival are excellent.
Acute surgical remodeling of the local LV anomalies
that focus on the subvalvular mitral apparatus may there-
fore have long-term beneficial effect that will cumulate
with the already consistent effect of mitral valvuloplasty.CONCLUSIONS
Mitral repair by means of a sling encircling and reapprox-
imating both PMs, setting a more normal ‘‘PM–mitral annu-
lus’’ anatomic relationship, completed by mitral
annuloplasty seems a more rational approach in patients
with ischemic MR. It restores mitral leaflet mobility, pre-
vents recurrent MR, and shows an effect on ventricular
dynamics in patients who are normally considered as poor
responders to an undersized ring.References
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Dr Robert A. Dion (Genk, Belgium). Dr Hvass, as you men-
tioned, our group in Leiden has demonstrated that a preoperative
cutoff value of the LV end-diastolic diameter of 65 mm is an inde-
pendent predictor of survival and of LV reverse remodeling. Below
this value, a stringent undersizing annuloplasty by two sizes using
a complete semirigid ring (Physio ring), as you also now use, yields
a coaptation length of at least 8 mm. In our hands, this is invariably
efficient in correcting MR without producing mitral stenosis and
also addresses LV remodeling, even after a follow-up of 5 years.
We also concluded that something else should be added to the
annuloplasty at the ventricular level in the presence of a more
dilated left ventricle, in case the LV end-diastolic diameter is
more than 65 mm.
There are, in my opinion, two ways to address the ventricular
level: either from the outside, such as using the CorCap, as we
have chosen in Leiden with initial promising results, or from the
inside, such as the PM resuspension described by Irving Kron
and his group, or the PM approximation by stitches proposed by
Matsui from Japan, or the PM sling that you already proposed
a while ago.ery c February 2010
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SI have been convinced by this brilliant idea and have used it in
addition to restrictive mitral annuloplasty in patients with dilated
ventricles exceeding 65-mm end-diastolic dimension with promis-
ing short-term results. Your patient cohort has a mean preoperative
LV end-diastolic diameter of 70 mm and therefore indeed corre-
sponds to the Leiden cohort, which had disappointing results:
a mortality of 50% at 5 years and an absent or less significant re-
verse remodeling in only 50% of the survivors. Only 2 of 29 pa-
tients in your group died after 3 years and 2 others required
a reoperation. This is a spectacular result, certainly if one considers
the amount of continuous reverse remodeling that you described
over 1 year.
I have a few questions. What is your current indication for per-
forming a PM sling in this group? Do you perform it systematically
or only in the presence of a dilated ventricle with more than 65-mm
end-diastolic diameter? Do you also take into account the inter-PM
distance, as Matsui recommends, doing something above 3 cm?
Dr Hvass. To answer the first question, I must admit that I do
not see the good responders. I am essentially having referred to me
the patients who already have very enlarged ventricles. It is more
or less a systematic approach since I am not seeing the other
patients, and I have been using it in all of these patients. It is
true that in all of these patients, the distance of the PMs is much
more than 3 cm.
Dr Dion. Thank you. In the last 10 patients, you write in the
manuscript that you no longer undersized the annuloplasty ring.
Did you measure the length of coaptation in these patients in
whom you did a sling with no restrictive mitral annuloplasty?
Dr Hvass. In the first group of patients, the ring was hardly un-
dersized. I mean, it was not two sizes. I was using the size of the
anterior leaflet as a guideline and sometimes wondering whether
I should undersize it or not, just for safety. Then when I became
very confident with the technique, I just took the normal size and
have been continuing that way. You do not need to undersize mitral
rings. When you have the mitral rings together, you have much
more mobility of the leaflets.
The height of the coaptation is very good. I do not try to get 8
mm each time, as you advocate, but it is between 5 and 8 mm in
all the cases. We never have very, very shallow coaptation heights
with this technique.
Dr Dion. Thank you. In my limited experience with your tech-
nique, I ended up in a 5-year-old child after the sling with a prolapse
of A1, A2, P1 after approximation of the PMs, probably because I
approximated the PMs with different heights. Did you encounter
this problem and have you considered additionally stitching to-
gether the tips of the PMs to prevent this problem and reinforce
your intraventricular repair?
Dr Hvass. I remember you talked about this problem with me
already, and I was a bit surprised because I have not encountered
it in any of my patients. I do not know how I would deal with it.
I do not know whether it would be necessary to put an additional
stitch at the tip of the PMs or not.The Journal of Thoracic and CaDr Steven F. Bolling (Ann Arbor, Mich). I disclose I have IP and
royalty rights to the GeoForm ring.
Dr Hvass, congratulations on your pioneering work. This clearly
is a ventricular problem and you have proposed a very interesting
operation that perhaps is technically demanding for the rest of us.
I have a particularly technical question. We know now that the clo-
sure cylinder of the mitral valve apparatus should be stacked as
a cylinder. Do you measure the sling, do you make it the same
size and diameter as the annuloplasty ring, or how do you size
the sling?
Dr Hvass. I do not size it. I just put it around the PMs and bring
the PMs into contact. That is the only measure I do. It has nothing to
do with the size of the mitral ring above it. It may not be a complete
cylinder, but that is the way I have been doing it.
Dr Richard J. Shemin (Los Angeles, Calif). No disclosures.
I have another question about intraoperative decision-making.
Obviously, there is often variability in the sizes and the distribution
of PMs, so what have you learned from your experience of when
not to do this, and are PMs that are asymmetrical a problem in get-
ting a good result?
Dr Hvass. As you saw from the slides, there was an initial mis-
take when I did leave a group of PMs out. I am very careful now to
look at the exact anatomy, what is happening below, and go around
all the PMs that are there.
DrR.W.M. Frater (Bronx, NY).Have you ever had to turn a pa-
tient down because of the irregularity of the anatomy?
Dr Hvass. No. I think it is quite unusual to have what is called
a type 4 mitral PM anatomy. I think it is very unusual.
Dr David H. Adams (New York, NY). Dr Hvass, I would like to
make a comment and then ask you a question. I think we have to
stop presenting slides that say that current strategy fails in 20%
to 50% of these patients. A lot of those patients were not down-
sized; a lot of those patients received partial flexible bands, which
is not done in most centers. We should start talking about patients
who had downsized remodeling rings and what that standard is
from Leiden and others as the benchmark. There is a recurrence
rate, probably 10% or 15%, but I think it is historical now to say
50% of ischemic MR repairs fail. I think it sets the bar too low
from the percutaneous side.
Having said that, I congratulate you for this really unique work
in trying to move PMs, but I am going to ask you for some more
science. Can you tell us about tethering angle, tethering area, and
depth of coaptation? Your MR grades were grade 2 to 4, so you
can have a big ventricle and still have mild MR. I am impressed
by your remodeling, but do you have more precise echo data on
the amount of tethering and what you are doing to that after you
do this operation compared with just annuloplasty?
Dr Hvass. We have data on the preoperative and postoperative
tethering, which I have been showing in all the previous meetings. I
decided not to show it this time because most people know it. We
have had the preoperative tethering that is going from 16mm to less
than 4 mm. There was a big, big change in that.rdiovascular Surgery c Volume 139, Number 2 423
